EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
17.74
+1.02 (6.10%)
At close: Dec 5, 2025, 4:00 PM EST
17.40
-0.34 (-1.92%)
After-hours: Dec 5, 2025, 6:43 PM EST
EyePoint Pharmaceuticals Employees
EyePoint Pharmaceuticals had 165 employees as of December 31, 2024. The number of employees increased by 44 or 36.36% compared to the previous year.
Employees
165
Change (1Y)
44
Growth (1Y)
36.36%
Revenue / Employee
$256,600
Profits / Employee
-$1,246,982
Market Cap
1.47B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EYPT News
- 17 days ago - EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration - GlobeNewsWire
- 19 days ago - EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - EyePoint Pharmaceuticals, Inc. (EYPT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments - GlobeNewsWire
- 4 weeks ago - EyePoint Announces Participation at Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 - GlobeNewsWire
- 7 weeks ago - EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study - Benzinga
- 7 weeks ago - EyePoint Announces Pricing of Public Offering - GlobeNewsWire